SCHEMBL22817587

SCHEMBL22817587

c1ccc(-c2ccccc2N(c2ccccc2)c2cccc3oc4c5ccccc5c(-c5ccc6ccccc6c5)cc4c23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.36
▸ PRKDC P78527 2/20 0.34
▸ CYP1A1 P04798 5/20 0.33
▸ CYP1B1 Q16678 4/20 0.33
▸ GPR84 Q9NQS5 1/20 0.32
▸ CYP1A2 P05177 4/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ GSTP1 P09211 1/20 0.31
▸ MIF P14174 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.30
▸ GGPS1 O95749 1/20 0.30
▸ MAOB P27338 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ ABCG2 Q9UNQ0 2/20 0.30
▸ PDE5A O76074 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ ABCB1 P08183 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22817952 0.99 ALOX5 (0.36) ALOX5PRKDCCYP1A1CYP1B1GPR84
SCHEMBL22817661 0.97 ALOX5 (0.36) ALOX5PRKDCCYP1A1CYP1B1GPR84
SCHEMBL22818247 0.97 ALOX5 (0.36) ALOX5PRKDCCYP1A1CYP1B1GPR84
SCHEMBL22817994 0.97 ALOX5 (0.36) ALOX5PRKDCCYP1A1CYP1B1GPR84
SCHEMBL22817990 0.95 ALOX5 (0.36) ALOX5PRKDCCYP1A1CYP1B1GPR84
SCHEMBL22818271 0.94 ALOX5 (0.43) ALOX5PRKDCCYP1A1CYP1B1GPR84
SCHEMBL22817964 0.94 ALOX5 (0.35) ALOX5PRKDCCYP1A1CYP1B1GPR84
SCHEMBL22817986 0.92 ALOX5 (0.37) ALOX5PRKDCCYP1A1CYP1B1GPR84
SCHEMBL22818302 0.92 ALOX5 (0.34) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL22818198 0.91 ALDH1A1 (0.33) ALOX5PRKDCCYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885PRKDC 2919/4885CYP1A1 450/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885PRKDC 2919/4885CYP1A1 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback